An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity

OJAE Ophorst, S Kostense, J Goudsmit, Rik de Swart, S Verhaagh, A Zakhartchouk, M Sprangers, Geert Amerongen, Selma Yüksel, Ab Osterhaus, MJE Havenga

Research output: Contribution to journalArticleAcademicpeer-review

71 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)3035-3044
Number of pages10
Publication statusPublished - 2004

Research programs

  • EMC MM-04-27-01

Cite this